Key result
In a rabbit model of myocardial infarction, treatment with G-CSF significantly reduced scar area at 3 months compared to saline (4.2 vs 7.9 mm2/slice/kg, P<0.05).
Why the study?
Does postinfarction G-CSF treatment improve cardiac function and accelerate healing in a rabbit model of myocardial infarction?
Does postinfarction G-CSF treatment improve cardiac function and accelerate healing in a rabbit model of myocardial infarction?
Post-MI G-CSF treatment in a rabbit model improves cardiac function and remodeling by accelerating the healing process and enhancing myocardial regeneration.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for G-CSF in post-MI remodeling; should not change clinical practice pending further studies.
BACKGROUND: We investigated whether the improvement of cardiac function and remodeling after myocardial infarction (MI) by granulocyte colony-stimulating factor (G-CSF) relates to acceleration of the healing process, in addition to myocardial regeneration. METHODS AND RESULTS: In a 30-minute coronary occlusion and reperfusion rabbit model, saline (S) or 10 microg x kg(-1) x d(-1) of human recombinant G-CSF (G) was injected subcutaneously from 1 to 5 days after MI. Smaller left ventricular (LV) dimension, increased LV ejection fraction, and thicker infarct-LV wall were seen in G at 3 months after MI. At 2, 7, and 14 days and 3 months after MI, necrotic tissue areas were 14.2+/-1.5/13.4+/-1.1, 0.4+/-0.1/1.8+/-0.5*, 0/0, and 0/0 mm2 x slice(-1) x kg(-1), granulation areas 0/0, 4.0+/-0.7/8.5+/-1.0*, 3.9+/-0.8/5.7+/-0.7,* and 0/0 mm2 x slice(-1) x kg(-1), and scar areas 0/0, 0/0, 0/0, and 4.2+/-0.5/7.9+/-0.9* mm2 x slice(-1) x kg(-1) in G and S, respectively (*P<0.05, G versus S). Clear increases of macrophages and of matrix metalloproteinases (MMP) 1 and 9 were seen in G at 7 days after MI. This suggests that G accelerates absorption of necrotic tissues via increase of macrophages and reduces granulation and scar tissues via expression of MMPs. Meanwhile, surviving myocardial tissue areas within the risk areas were significantly increased in G despite there being no difference in LV weight, LV wall area, or cardiomyocyte size between G and S. Confocal microscopy revealed significant increases of cardiomyocytes with positive 3,3,3',3'-tetramethylindocarbocyanine perchlorate and positive troponin I in G, suggesting enhanced myocardial regeneration by G. CONCLUSIONS: The acceleration of the healing process and myocardial regeneration may play an important role for the beneficial effect of post-MI G-CSF treatment.
No takes yet. Share an insight, caveat, or question.
Minatoguchi et al. (2004) studied Myocardial infarction. Human recombinant G-CSF vs. Saline was evaluated on Scar area at 3 months (mm2 x slice(-1) x kg(-1)) (p=<0.05). In a rabbit model of myocardial infarction, treatment with G-CSF significantly reduced scar area at 3 months compared to saline (4.2 vs 7.9 mm2/slice/kg, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: